Currently there are no small molecule tools to investigate the biological functions of apelin and its receptor. Apelin is the endogenous peptide ligand for the G-protein coupled receptor (GPCR) APJ (angiotensin II receptor-like 1, AGTRL-1 and APLNR). Until the discovery of apelin, APJ was an orphan GPCR. APJ is coupled to Gai, and has been shown in cell culture to inhibit adenylate cyclase. The APJ gene encodes a receptor that most closely resembles the angiotensin receptor AT1. However, the APJ receptor does not bind angiotensin II. Underscoring the emerging importance of the apelin/APJ system, recent studies have shown that apelin reduces the extent of atherosclerotic lesions in ApoE-/- mice, and opposes the development of abdominal aortic aneurysms. Additional research has revealed that APJ forms a heterodimer with the Ang II receptor AT1, and that this complex facilitates antagonism of Ang II signaling by apelin. Despite these exciting results, there remains a multitude of unanswered questions regarding the role of apelin and APJ in physiology and pathology. The aim of this assay is to identify small molecule antagonists of the human angiotensin II receptor type 1 (AT1). The dose response assay is developed and performed to evaluate selectivity of hits originally identified in an uHTS luminescent beta-arrestin assay for antagonists of the APJ receptor. This AT1 antagonist assay utilizes the same luminescent b-Arrestin-based assay readout as the uHTS APJ primary assay. In both assays we utilize enzyme-fragment complementation to directly measure GPCR activation. Unlike imaging or other second messenger assays, the DiscoveRx b-Arrestin assay allows for a direct measure of GPCR activation by detection of b-Arrestin binding to the KOR1 receptor. In this system, b-Arrestin is fused to an N-terminal deletion mutant of b-gal (termed the enzyme acceptor of EA) and the GPCR of interest is fused to a smaller (42 amino acids), weakly complementing fragment termed ProLin. In cells that stably express these fusion proteins, ligand stimulation results in the interaction of b-Arrestin and the Prolink-tagged GPCR, forcing the complementation of the two b-gal fragments and resulting in the formation of a functional enzyme that converts substrate to detectable signal. This assay is a follow-up to "uHTS identification of small molecule antagonists of the APJ receptor  via a luminescent beta-arrestin assay", AID 2521. A. Brief Description of the Assay: The purpose of this assay is to detect antagonists that cause the activation the angiotensin II receptor type  1 (AT1) in the CHO-K1 AGTR-1 b-Arrestin Cell Line in 1536-well plate format in HTS mode. B. Materials: Angiotensin II receptor type 1 (AGTR-1) Cell Line (DiscoveRx, Cat# 93-0312C2) F12 nutrient mix HAMs (Invitrogen, Cat# 11765) Fetal Bovine Serum, heat-inactivated (Hyclone, Cat# SH30396) 100X Penicillin/Streptomycin Solution (Invitrogen, Cat#15140-122) Hygromycin B (Roche, Cat# 10843555001) Geneticin (MPBiomedicals, Cat # 1672548) Trypsin-EDTA 0.25% (Invitrogen, Cat# 25200-056) Cell Dissociation Buffer (Invitrogen, Cat # 13151) DPBS (Hyclone, Cat# 30028.02) T225 TC Flask (Nunc, Cat# 159934) Cell strainer, 40 um (BD, Cat# 352340) 1536-well, white, solid-bottom, Kalypsys compatible, TC plate (Corning) Angiotensin II (Sigma-Aldrich, Cat # A9525) PathHunter Detection Reagents (DiscoveRx, Cat# 93-0001) Galacton Star Emerald 11 Cell Assay Buffer C. uHTS Procedures: Day1 - Cell Seeding 1) Plate 500 cells/well in 5 uL of Assay Media into columns 1-48 of a 1536-well assay plate 2) Centrifuge plates at 500 rpm for 1 minute on an Eppendorf 5810 centrifuge 3) Incubate overnight at 37 degrees, 100% relative humidity, 5% CO2 for 16-18 hours Day2 - Compound Addition 1) Centrifuge compound plates at 500 rpm for 1 minute on an Eppendorf 5810 centrifuge 2) Using LabCyte Echo, transfer varying volumes of 10 mM test compounds in DMSO into assay plate and back fill wells with DMSO (total of 80 nL) to achieve appropriate dose response concentrations and range, and a final DMSO concentration of 1.32%. Test compounds are distributed into Columns 5-44. Transfer 80 nL of DMSO to positive and negative control wells in Columns 1-4 and 45-48. 3) Immediately following compound/DMSO transfer via the Echo, transfer 1 ul/well of Assay Media to the positive control wells in Columns 1-4. 4) Add 1 ul/well of 300 nM Angiotensin II (FAC = 50 nM) in Assay Media to Columns 3-48 containing test compound and positive control wells 5) Centrifuge plates at 500 rpm for 1 minute on an Eppendorf 5810 centrifuge 6) Incubate plates at 25 degrees in the dark for 90 minutes. 7) Following 90 minute incubation, deliver 3.0 uL of Detection Reagent solution to each assay plate (Columns 1-48) using a Kalypsys dispenser. 8) Centrifuge plates at 2000 rpm for 3 minute on a Eppendorf 5810 centrifuge 9) Incubate plates for 60 minutes at 25 degrees in the dark. 10) Read plates using the Viewlux using a luminescence protocol. E. Recipes: Growth Media F12 nutrient mix HAMs supplemented with 10% hi-FBS, 1X Penicillin/Streptomycin; selection reagents: 300 ug/ml Hygromycin B, 800 ug/ml Geneticin Assay Media Same as Growth Media, but with 6.0% FBS instead of 10.0%. Trypsin Dilute 0.25% Trypsin/EDTA to 0.05% Trypsin/EDTA using DPBS Positive Control Angiotensin II (FAC = 50 nM, ~EC80) Detection Reagent Use the following ratio to prepare the detection reagent: Galacton Star : Emerald II : Assay Buffer = 1 : 5 : 19
bao:BAO_0000541 "2521" ; # "is counter assay of" -> "2521"
bao:BAO_0000812 "2569" ; # "has summary assay" -> "2569"
bao:BAO_0000812 "2580" ; # "has summary assay" -> "2580"
bao:BAO_0000210 bao:BAO_0000032 ; # "has assay stage" -> "secondary assay"
bao:BAO_0001070 bao:BAO_0001064 ; # "has alternate target assay" -> "alternate target assay"
bao:BAO_0000205 bao:BAO_0000219 ; # "has assay format" -> "cell-based format"
bao:BAO_0000409 bao:BAO_0000410 ; # "assay measurement type" -> "endpoint assay"
bao:BAO_0002851 "single parameter" ; # "has assay readout content parametricity" -> "single parameter"
bao:BA0_0090012 bao:BAO_0000284 ; # "has participant" -> "G protein coupled receptor" || bao:BAO_0003102 bao:BAO_00020144 ; # "has role" -> "target"
bao:BAO_0002855 bao:BAO_0200056 ; # "is bioassay type of" -> "beta galactosidase reporter gene assay"
bao:BAO_0000212 bao:BAO_0000123 ; # "has assay method" -> "binding assessment method"
bao:BAO_0000212 bao:BAO_0000406 ; # "has assay method" -> "protein fragment complementation method"
bao:BAO_0000207 bao:BAO_0000051 ; # "has detection method" -> "chemiluminescence"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Small molecule antagonists of the apelin receptor (APJ)" ; # "screening campaign name" -> "Small molecule antagonists of the apelin receptor (APJ)"
bao:BAO_0002853 "Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor" ; # "has assay title" -> "Dose Response screen for antagonists of Angiotensin II Receptor Type 1 to assess selectivity of uHTS small molecule antagonists hits of the APJ receptor"
bao:BAO_0002854 bao:BAO_0000010 ; # "has bioassay type" -> "functional"
bao:BAO_0002867 bao:BAO_0000516 ; # "has assay footprint" -> "1536 well plate"
bao:BAO_0002863 bao:BAO_0000535 ; # "has concentration throughput" -> "multiple concentration"
bao:BAO_0000109 "25 degree celsius" ; # "has temperature value" -> "25 degree celsius"
bao:BAO_0002833 "90 minute" ; # "has incubation time value" -> "90 minute"
bao:BA0_0090012 "\"assay media, DMSO\"" ; # "has participant" -> ""assay media, DMSO""
bao:BAO_0000740 bao:BAO_0000080 ; # "has assay control" -> "positive control"
bao:BA0_0090012 "\"assay media , 50 nanomolar Angiotensin II EC80, DMSO\"" ; # "has participant" -> ""assay media , 50 nanomolar Angiotensin II EC80, DMSO""
bao:BAO_0000740 bao:BAO_0000079 ; # "has assay control" -> "negative control"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "Layton Smith" ; # "material entity assay provider" -> "Layton Smith" || bao:BAO_0003102 bao:BAO_0000027 ; # "has role" -> "assay provider"
bao:BAO_0002020 bao:BAO_0000373 ; # "has assay phase characteristic" -> "heterogeneous phase"
bao:BAO_0000118 "1%" ; # "DMSO" -> "1%"
bao:BAO_0002000 bao:BAO_0000848 ; # "has measured entity" -> "Angiotensin II" || bao:BAO_0003102 bao:BAO_00020138 ; # "has role" -> "potentiator"
bao:BA0_0090012 "Type-1 angiotensin II receptor" ; # "has participant" -> "Type-1 angiotensin II receptor"
bao:BAO_0002004 <http://purl.obolibrary.org/obo/CLO_0002462> ; # "has cell line" -> "CHO-K1 cell"
bao:BAO_0002921 <http://purl.obolibrary.org/obo/NCBITaxon_9606> ; # "has organism" -> "Homo sapiens"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "P30556" ; # "uniprot ID" -> "P30556"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "9606" ; # "NCBI taxonomy ID" -> "9606"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "10% fetal bovine serum" ; # "material entity culture serum" -> "10% fetal bovine serum" || bao:BAO_0003102 bao:BAO_0002596 ; # "has role" -> "culture serum"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"F12 nutrient mix HAMs supplemented with 10% hi-FBS, 1X Penicillin/Streptomycin\"" ; # "material entity culture medium" -> ""F12 nutrient mix HAMs supplemented with 10% hi-FBS, 1X Penicillin/Streptomycin""
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "\"selection reagents: 300ug/ml Hygromycin B, 800ug/ml Geneticin\"" ; # "material entity culture medium" -> ""selection reagents: 300ug/ml Hygromycin B, 800ug/ml Geneticin"" || bao:BAO_0003102 bao:BAO_0000114 ; # "has role" -> "culture medium"
bao:BAO_0002922 "\"F12 nutrient mix HAMs supplemented with 6% hi-FBS, 1X Penicillin/Streptomycin\"" ; # "has assay medium" -> ""F12 nutrient mix HAMs supplemented with 6% hi-FBS, 1X Penicillin/Streptomycin""
bao:BAO_0002922 "\"selection reagents: 300 ug/ml Hygromycin B, 800 ug/ml Geneticin\"" ; # "has assay medium" -> ""selection reagents: 300 ug/ml Hygromycin B, 800 ug/ml Geneticin""
bao:BAO_0002922 bao:BAO_0000596 ; # "has assay medium" -> "assay medium"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "6% fetal bovine serum" ; # "material entity assay serum" -> "6% fetal bovine serum"
bao:BAO_0002923 bao:BAO_0002597 ; # "has assay serum" -> "assay serum"
bao:BAO_0000212 bao:BAO_0000246 ; # "has assay method" -> "stable transfection"
bao:BAO_0000550 "Expressing the Angiotensin II receptor type 1 (AGTR-1) and beta-arrestin (DiscoveRx #93-0312C2)" ; # "DNA construct" -> "Expressing the Angiotensin II receptor type 1 (AGTR-1) and beta-arrestin (DiscoveRx #93-0312C2)"
bao:BAO_0003105 "\"angiotensin II receptor, type 1\"" ; # "has function" -> ""angiotensin II receptor, type 1""
bao:BAO_0003105 "\"arrestin, beta 1\"" ; # "has function" -> ""arrestin, beta 1""
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "185" ; # "construct gene ID" -> "185"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "408" ; # "construct gene ID" -> "408"
bao:BAO_0002662 bao:BAO_0002157 ; # "has quality" -> "native form"
bao:BAO_0002662 bao:BAO_0000228 ; # "has quality" -> "fused"
bao:BAO_0002897 bao:BAO_0000360 ; # "has preparation method" -> "recombinant expression"
bao:BA0_0090012 bao:BAO_0000750 ; # "has participant" -> "Beta-galactosidase"
bao:BAO_0002000 bao:BAO_0002001 ; # "has measured entity" -> "measured entity"
bao:BAO_0002857 bao:BAO_0000261 ; # "has signal direction" -> "signal decrease corresponding to inhibition"
bao:BAO_0000308 bao:BAO_0000988 ; # "has assay kit" -> "PathHunter Beta-Arrestin Assay"
bao:BAO_0000308 bao:BAO_0000248 ; # "has assay kit" -> "assay Kit"
bao:BAO_0000737 bao:BAO_0000893 ; # "has manufacturer" -> "DiscoveRx" || bao:BAO_0003102 bao:BAO_0002626 ; # "has role" -> "biologics and screening manufacturer"
bao:BA0_0090012 bao:BAO_0000176 ; # "has participant" -> "small molecule" || bao:BAO_0003102 bao:BAO_00020137 ; # "has role" -> "perturbagen"
bao:BAO_0000212 bao:BAO_0000574 ; # "has assay method" -> "single perturbagen"
bao:BAO_0002865 bao:BAO_0000691 ; # "uses detection instrument" -> "ViewLux ultraHTS Microplate Imager"
bao:BAO_0000737 bao:BAO_0000297 ; # "has manufacturer" -> "Perkin Elmer" || bao:BAO_0003102 bao:BAO_0002628 ; # "has role" -> "instrumentation manufacturer"
bao:BAO_0000208 bao:BAO_0000190 ; # "has endpoint" -> "IC50"
bao:BAO_0000183 <http://purl.org/obo/owl/UO#UO_0000064> ; # "has concentration unit" -> "micromolar"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "2" ; # "PubChem TID" -> "2"
bao:BAO_0002787 "6" ; # "has concentration-point number" -> "6"
bao:BAO_0002845 "2" ; # "has repetition point-number" -> "2"
bao:BAO_0000196 bao:BAO_0000441 ; # "has mode of action" -> "competitive binding"
bao:BAO_0002864 bao:BAO_0000533 ; # "has repetition throughput" -> "multiple repetition"
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> "mp" ; # "Annotated by" -> "mp"
